Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.43 |
| ▸ | CTH | P32929 | 1/20 | 0.43 |
| ▸ | CBS | P35520 | 1/20 | 0.43 |
| ▸ | THPO | P40225 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | APEX1 | P27695 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | LDHA | P00338 | 1/20 | 0.32 |
| ▸ | SRR | Q9GZT4 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALKBH5 | Q6P6C2 | 1/20 | 0.32 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.32 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.30 |
| ▸ | GLRA1 | P23415 | 1/20 | 0.30 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.30 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9595597 | 0.84 | TSHR (0.36) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL27651545 | 0.82 | CA1 (0.41) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL27550825 | 0.80 | CAMK2A (0.34) | TSHRCTHCBSTHPO | |
| SCHEMBL168709 | 0.79 | — | — | |
| Ammonia Solution, Strong SCHEMBL440382 | 0.78 | CA2 (0.43) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL11280732 | 0.77 | TSHR (0.39) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL900920 | 0.77 | — | — | |
| Ammonia Solution, Strong SCHEMBL11317665 | 0.77 | TSHR (0.39) | TSHRCTHCBSTHPOTHRB | |
| Methane SCHEMBL9595604 | 0.77 | TSHR (0.39) | TSHRCTHCBSTHPOTHRB | |
| SCHEMBL28279642 | 0.77 | TSHR (0.39) | TSHRCTHCBSTHPOTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4637856-B1 | VASCULAR SCAFFOLD HAVING A RARE-EARTH METAL RADIOPAQUE MARKER | MEKO MFG E K (DE) | 2026-02-25 | — | — | EP | claimed |
| EP-3562526-B1 | STENT MADE OF A BIODEGRADABLE MAGNESIUM ALLOY WITH A MAGNESIUM FLUORIDE COATING AND AN ORGANIC COATING | MEKO MFG E K (DE) | 2025-11-12 | — | — | EP | claimed |
| EP-4637856-A1 | VASCULAR SCAFFOLD HAVING A RARE-EARTH METAL RADIOPAQUE MARKER | MeKo Manufacturing e.K. (DE) | 2025-10-29 | — | — | EP | claimed |
| WO-2025120167-A1 | VASCULAR SCAFFOLD HAVING A RARE-EARTH METAL RADIOPAQUE MARKER | MEKO MANUFACTURING E.K. (DE) | 2025-06-12 | — | — | WO | claimed |
| EP-4566639-A1 | VASCULAR SCAFFOLD HAVING A RARE-EARTH METAL RADIOPAQUE MARKER | MeKo Manufacturing e.K. (DE) | 2025-06-11 | — | — | EP | claimed |
| US-20230124539-A1 | BINDER FOR POSITIVE ELECTRODE OF LITHIUM ION BATTERY, SLURRY FOR FORMING POSITIVE ELECTRODE MIXTURE LAYER OF LITHIUM ION BATTERY, POSITIVE ELECTRODE FOR LITHIUM ION BATTERY, AND LITHIUM ION BATTERY | TOKYO UNIVERSITY OF SCIENCE FOUNDATION (JP) | 2023-04-20 | — | — | US | claimed |
| EP-4116332-A1 | BINDER FOR POSITIVE ELECTRODE OF LITHIUM-ION BATTERY, SLURRY FOR FORMING POSITIVE-ELECTRODE MIX LAYER OF LITHIUM-ION BATTERY, POSITIVE ELECTRODE FOR LITHIUM-ION BATTERY, AND LITHIUM-ION BATTERY | Tokyo University of Science Foundation (JP) | 2023-01-11 | — | — | EP | claimed |
| CN-115244738-A | Binder for lithium ion battery positive electrode, slurry for forming lithium ion battery positive electrode mixture layer, lithium ion battery positive electrode, and lithium ion battery | 学校法人东京理科大学 | 2022-10-25 | — | — | CN | claimed |
| US-11167065-B2 | Shellac and paclitaxel coated catheter balloons | EUROCOR TECH GMBH (DE) | 2021-11-09 | — | — | US | claimed |
| CN-112972400-A | Rapidly disintegrable minodronic acid granules and preparation method thereof | 华侨大学 | 2021-06-18 | — | — | CN | claimed |
| US-20100076544-A1 | BIODEGRADABLE VASCULAR SUPPORT | HEMOTEQ AG (DE) | 2010-03-25 | — | — | US | claimed |
| US-20100063585-A1 | MANUFACTURE, METHOD AND USE OF ACTIVE SUBSTANCE-RELEASING MEDICAL PRODUCTS FOR PERMANENTLY KEEPING BLOOD VESSELS OPEN | HEMOTEQ AG (DE) | 2010-03-11 | — | — | US | claimed |
| US-20090227537-A1 | SULFATED POLYSACCHARIDES AND USES THEREOF IN MEDICAL TREATMENT | SYSTAGENIX WOUND MANAGEMENT (US), INC. (US) | 2009-09-10 | — | — | US | claimed |
| EP-1435877-B1 | COATING OF STENTS FOR PREVENTING RESTENOSIS | HEMOTEQ AG (DE) | 2009-04-15 | — | — | EP | claimed |
| US-20080199506-A1 | Lattice or mesh-like structure; covering with thin film over interstices and supports with multilayer polymer | HEMOTEQ AG (DE) | 2008-08-21 | — | — | US | claimed |
| EP-1501566-B1 | MEDICAL PRODUCTS COMPRISING A HAEMOCOMPATIBLE COATING, PRODUCTION AND USE THEREOF | HEMOTEQ AG (DE) | 2008-08-13 | — | — | EP | claimed |
| EP-1667743-B1 | BIOCOMPATIBLE, BIOSTABLE COATING OF MEDICAL SURFACES | HEMOTEQ AG (DE) | 2008-01-02 | — | — | EP | claimed |
| EP-1501565-B1 | COMPOUNDS AND METHOD FOR COATING SURFACES IN A HAEMOCOMPATIBLE MANNER | HEMOTEQ GMBH (DE) | 2006-11-02 | — | — | EP | claimed |
| US-20050129731-A1 | Biocompatible, biostable coating of medical surfaces | HEMOTEQ AG (DE) | 2005-06-16 | — | — | US | claimed |
| EP-0925310-B1 | USE OF SULFATED POLYSACCHARIDES FOR THE TREATMENT OF A CHRONIC WOUND | JOHNSON & JOHNSON MEDICAL LTD (GB) | 2000-08-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063585-A1 | MANUFACTURE, METHOD AND USE OF ACTIVE SUBSTANCE-RELEASING MEDICAL PRODUCTS FOR PERMANENTLY KEEPING BLOOD VESSELS OPEN | RICTOR, VEGFA, RPTOR | TSHR 3313/4885CTH 3720/4885CBS 3286/4885 |
| US-20050129731-A1 | Biocompatible, biostable coating of medical surfaces | MSR1, CD44, PIGS | TSHR 4305/4885CTH 866/4885CBS 628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.